## TER: Teradyne, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -0.1% below STRENGTH zone (3.0-6.0%); PEG 1.63 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($179.02)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Teradyne CEO Sells Over 1,100 Shares**
- Source: TradingView â€” Track All Markets | 20251215T170844 | Neutral | Relevance: 100%
- Gregory Stephen Smith, President and CEO of Teradyne, sold 1,108 shares of common stock on December 12, 2025, for a total of $223,051. The sale was executed under a Rule 10b5-1 adopted on February 4, 2025, and Smith now directly owns 93,408 shares of Teradyne.

**2. Insider Sell: Gregory Smith Sells Shares of Teradyne Inc (TER)**
- Source: GuruFocus | 20251215T200814 | Somewhat-Bearish | Relevance: 100%
- Gregory Smith, President and CEO of a Teradyne Inc subsidiary, sold 1,108 shares of Teradyne Inc (TER) on December 12, 2025. This transaction leaves him with 93,408.995 shares, and over the past year, he has sold 11,700 shares without any purchases. The stock, trading at $201.31, appears significantly overvalued with a price-to-GF-Value ratio of 1.71, and its P/E ratio of 70.89 is higher than both the industry and company historical medians.

**3. Teradyne CEO Smith sells $223k in company stock By Investing.com**
- Source: Investing.com Canada | 20251215T180829 | Somewhat-Bullish | Relevance: 100%
- Teradyne CEO Gregory Stephen Smith recently sold 1,108 shares of company stock for $223,051, as part of a pre-arranged trading plan. This comes as Teradyne reports an 18% increase in Q3 revenue due to AI-related semiconductor testing demand, leading to several analyst upgrades and plans for a new robotics operations hub. The company also declared a quarterly dividend of $0.12 per share.

**4. Goldman Sachs Upgrades Teradyne to Buy From Sell, Adjusts Price Target to $230 From $148**
- Source: marketscreener.com | 20251215T120858 | Bullish | Relevance: 100%
- Goldman Sachs has upgraded Teradyne (NASDAQ: TER) to a "Buy" rating from "Sell," significantly increasing its price target to $230 from $148. This positive revision indicates a strong belief in the semiconductor equipment and testing company's future performance. The article also mentions Teradyne's plans to open a US Robotics Hub in Metro Detroit in 2026.

**5. Teradyne, Inc. $TER Shares Sold by Nikko Asset Management Americas Inc.**
- Source: MarketBeat | 20251214T105557 | Somewhat-Bullish | Relevance: 100%
- Nikko Asset Management Americas Inc. has reduced its stake in Teradyne, Inc. by 5.3%, selling 93,773 shares and now holding 1,690,045 shares valued at approximately $151.94 million. This makes Teradyne the 18th-largest position in their investment portfolio. Additionally, Teradyne's CEO, Gregory S. Smith, sold 1,108 shares, while institutional investors and hedge funds collectively own 99.77% of the company's stock.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Stifel | $225 | $162 | +39% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Stifel | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 7 ($0.08M) |
| Sells | 6 ($0.76M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+2.1%)
- Blackrock Inc.: 8.4% (-7.2%)
- JPMORGAN CHASE & CO: 5.4% (+126.5%)
- State Street Corpora: 4.0% (+0.3%)
- Ameriprise Financial: 3.0% (+6.8%)

### Key Risks

1. High beta (1.85) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.63 elevated, pricing in significant growth expectations. Forward P/E 37.9x attractive for 46% earnings growth. Quality metrics strong (margin 16%). Balance sheet: low leverage (D/E 0.46). Revenue growth strong at 23% YoY. Analyst sentiment positive (1 raises, avg +39%). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $31.0B |
| Beta | 1.85 |
| 52W Range | $65.77 - $205.00 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.63 |
| Forward P/E | 37.9 |
| Current P/E | 55.3 |
| YoY Growth | 45.8% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 4.7% to -0.1% (-4.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.1pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 60. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.13% (CS: 26) | Neutral |
| RSI_14 | 59.7 | Neutral |
| MACD Histogram | 0.16 | Bullish |
| vs SMA20 | 1.060x | Above |
| vs SMA50 | 1.158x | Above |
| vs SMA200 | 1.713x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $194.70
- **Stop Loss:** $179.02 (8.1% risk)
- **Target:** $210.38 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 63
- **Position Value:** $12,266.10
- **Portfolio %:** 12.27%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-28 (Est: $1.36)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.79 | $0.85 | +7.4% |
| 2025Q2 | $0.54 | $0.57 | +4.9% |
| 2025Q1 | $0.62 | $0.75 | +21.7% |
| 2024Q4 | $0.91 | $0.95 | +4.5% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*